Patent US3932627A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3932627A Expired / Lapsed US ⏱️ 0.0 years remaining

Siver-heparin-allantoin complex

Assignee: Rescue Products Inc
•
Filing: 1974-02-04
•
Granted: 1976-01-13
•
Expires: 1994-02-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Silver-heparin-allantoin complex and process for making same is disclosed. The silver-heparin-allantoin complex is prepared by a novel process in either powder or solution form. The silver-heparin-allantoin complex provides a non-thrombogenic, self-sterilizing compound for application to polymeric devices such as prosthetic values, small diameter arterial grafts and the like to avoid thrombus formation and infection of polymeric devices.

Inventors

  • 👤 Harry W. Margraf

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:43
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61L; A61L27/00; A61L27/50; A61L27/54; A61L33/00; A61L33/0005; A61L33/0011; C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; A61L2300/00; A61L2300/10; A61L2300/102; A61L2300/104; A61L2300/20; A61L2300/23; A61L2300/236; A61L2300/40; A61L2300/404; A61L2300/42; A61L2300/80; A61L2300/802

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 16 words
A non-thrombogenic and anti-microbial complex for application to body contact polymeric devices consisting essentially of silver-heparin-allantoinate.
Claim 2
Dependent Claim 16 words
A non-thrombogenic and anti-microbial complex for application to body contact polymeric devices consisting essentially of silver-heparin-allantoinate.
Claim 3
Dependent Claim 24 words
The composition of claim 1 in which the silver-heparin-allantionate is present in solution in an amount of 60 ml per 100 ml of solution.
Claim 4
Dependent Claim 39 words
The composition of claim 2 in which silver is present in the amount by weight of 0.8%, allantoinate is present in the amount of 2.8%, and there are approximately 40,000 units of heparin in each 100 ml of solution.

References Cited (Backward Citations)

US2336131A Cited
US3549409A Cited
US3673612A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-01-12 1979-07-14 1980-01-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-01-12 1983-07-14 1984-01-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-01-12 1987-07-14 1988-01-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag